Hangzhou AGS MedTech Co. Ltd. A
Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more
Hangzhou AGS MedTech Co. Ltd. A - Asset Resilience Ratio
Hangzhou AGS MedTech Co. Ltd. A (688581) has an Asset Resilience Ratio of 18.93% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Hangzhou AGS MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥500.86 Million | 18.93% |
| Total Liquid Assets | CN¥500.86 Million | 18.93% |
Asset Resilience Insights
- Good Liquidity Position: Hangzhou AGS MedTech Co. Ltd. A maintains a healthy 18.93% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hangzhou AGS MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Hangzhou AGS MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FluroTech Ltd
OTCQB:FLURF |
Medical Devices | 0.00% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Hangzhou AGS MedTech Co. Ltd. A (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Hangzhou AGS MedTech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 26.32% | CN¥671.22 Million | CN¥2.55 Billion | +22.79pp |
| 2023-12-31 | 3.54% | CN¥82.42 Million | CN¥2.33 Billion | -8.09pp |
| 2022-12-31 | 11.63% | CN¥55.01 Million | CN¥473.13 Million | +11.31pp |
| 2021-12-31 | 0.32% | CN¥1.09 Million | CN¥341.99 Million | -- |